CurAegis Technologies, Inc. 4
4 · CurAegis Technologies, Inc. · Filed Dec 8, 2016
Insider Transaction Report
Form 4
SICONOLFI GARY A
Director
Transactions
- Conversion
Common Stock
2016-12-06+250,000→ 863,333 total - Conversion
Series C Voting Convertible Preferred Stock
2016-12-06−250,000→ 0 totalFrom: 2011-09-23Exp: 2021-09-23→ Common Stock (250,000 underlying) - Award
Convertible Promissory Note
2016-12-07$0.25/shExercise: $0.25From: 2016-12-07Exp: 2021-12-07→ Common Stock - Award
Common Stock Purchase Warrant
2016-12-07$0.25/sh+24,000$6,000→ 24,000 totalExercise: $0.25From: 2016-12-07Exp: 2026-12-07→ Common Stock (24,000 underlying)
Footnotes (2)
- [F1]The reporting person converted 250,000 shares of Series C Voting Convertible Preferred Stock, par value $.01 per share, into an equivalent number of shares of Common Stock of the Company, par value $.01 per share, resulting in his acquisition of 250,000 shares of Common Stock of the Company.
- [F2]The reported securities are included within 250,000 Investment Units purchased by the reporting person on 09/23/2011. Each Investment Unit consists of one (1) share of the Company's Series C Voting Convertible Preferred Stock, par value $.01 per share, initially convertible into an equivalent number of shares of Common Stock of the Company, par value $.01 per share, and a warrant to purchase one-tenth (1/10) of a share of Common Stock exercisable immediately for ten years at an initial exercise price equal to the greater of (i) $.01, or (ii) 80% of the volume weighted average sales price per share of the Company's Common Stock during the ten consecutive trading days immediately preceding the notice of exercise.